140 doctors, 300 nurses, and a team of administrative and technical support participated in the trial
15 thousand volunteers from 107 nationalities participate in the trials of the "Covid-19" vaccine
The volunteers received regular medical check-ups. From the source
Abdullah Al Hamed. From the source
Abdul Rahman Al Owais: "The UAE strengthens cooperation with international partners to develop a safe vaccine that protects against disease."
picture
The world's first clinical trials of the third phase of the inactive "Covid-19" vaccine, underway in the UAE, have achieved a new milestone with 15,000 volunteers from 107 nationalities receiving a dose of the vaccine in less than a month.
The experiments began on July 16 in Abu Dhabi, and more than 140 doctors, 300 nurses and many administrative and technical support personnel participated in it, as the volunteers received regular medical examinations, in addition to the full support necessary to monitor and ensure their safety.
In detail, the first clinical trials in the world for the third phase of the inactive "Covid-19" vaccine, underway in the UAE, have achieved a new achievement with 15,000 volunteers from 107 nationalities receiving the vaccine dose in less than a month.
The experiments were launched on July 16 in Abu Dhabi under the management of the "G42 Healthcare" company, in partnership with the Ministry of Health and Community Protection and the Department of Health - Abu Dhabi, and "Sinopharma CNBG", one of the leading vaccine manufacturers that developed the inactive vaccine. . The door to volunteering is still open via the following link: www.4humanity.ae.
More than 140 doctors, 300 nurses, and many administrative and technical support personnel contributed to this experiment, as volunteers received regular medical examinations, in addition to all the necessary support to monitor and ensure their safety.
The participation of 15,000 people in this clinical trial of the third phase of the inactive vaccine for the "Covid-19" virus is a global achievement, as the world approaches the first safe vaccine that has been tested and developed at the highest level of international scientific standards.
The Ministry of Health and Community Protection, the Abu Dhabi Department of Health, the "Synopharm CNBG" and the "G42 Health Care" company renewed their thanks to all volunteers for their great service to humanity, stressing that it is without such an active and effective participation in the experiments. Scientific cannot develop a safe vaccine.
The volunteers benefited from the ease of procedures that enabled them to enter easily and conveniently to the Abu Dhabi National Exhibition Center and Al-Qareen Center in the Emirate of Sharjah to conduct experiments. To maintain their health and safety.
The Minister of Health and Community Protection, Abdul Rahman bin Muhammad Al Owais, said, “It is a day when we are proud of all those who participated in these experiences, and we look forward to continuing to play a vital role in these efforts during the coming months,” adding that the achievement of this achievement is a living testament to the commitment and partnership of the concerned bodies. Working together to conduct the largest possible number of medical examinations, and provide the necessary care for those infected with the infection, at the same time strengthening the UAE's cooperation with international partners to develop a safe vaccine that protects against the disease.
Yesterday, the Department of Health - Abu Dhabi announced the suspension of receiving volunteers wishing to participate in the world's first clinical trial for the third phase of the inactive Covid-19 virus vaccine, which was developed by the "Synopharma CNBG" company, in both clinics. Abu Dhabi National Exhibition Center (ADNEC) and Al-Qarayen Health Center in the Emirate of Sharjah, until next Saturday, to resume work on Sunday according to a different working mechanism that requires prior registration to obtain an appointment.
The department said that due to the increasing demand of volunteers to participate in clinical trials for the third phase of the inactive "Covid-19" vaccine, the reception of new applications at the field clinic specialized in experiments for the "Covid-19" vaccine in ADNEC centers and "health clues" has been stopped. », Starting from Thursday until next Saturday, August 15, indicating that the operations in both centers will resume on Sunday, August 16, provided that the current volunteers are received within the specified daily dates, and more volunteers can participate in the experiments by registering on the website only.
The department asked volunteers wishing to participate in the experiments to visit 4humanity.ae to provide the required details and their contact information to those in charge of this initiative, noting that participation in the experiments is available to individuals from the age of 18 to 60 years of all races and nationalities after conducting the necessary medical examinations.
For its part, the "G42 Healthcare" company announced a new program to manage the health care for volunteers in the trials of the "Covid-19" vaccine, in cooperation with WHOOP, which specializes in electronic wearable devices. The partnership will allow volunteers to benefit from health and fitness tracking devices. With the aim of measuring the vital signs of the body, this is the first experimental phase of its kind that includes a wearable technology, which will include thousands of volunteers participating in the experiments.
Volunteers participating in clinical trials at both ADNEC Center in Abu Dhabi and Al Qurain Center in Sharjah, including volunteers who will receive the second dose of the vaccine, will be able to advance their volunteering paths using new wearable devices that will enable them to monitor heart rates, breathing and sleep tracking. Quality, and more.
“We believe that giving volunteers the opportunity to use the WHOOP Strap 3.0 Sport Bracelet will enhance their confidence in the experimental process by enabling them to monitor many health and vital indicators on a daily basis,” said Ashish Kochi, CEO of G42 Healthcare. This complements the global clinical expertise that UAE healthcare workers provide to the volunteers, and will help maintain their safety and health throughout the trial process. ”
The first to volunteer in clinical trials
Sheikh Abdullah bin Muhammad Al Hamed, head of the Department of Health in Abu Dhabi, who was the first to volunteer to test the vaccine in the world, as he received the first and second doses of the vaccine: “I am proud that I was the first to volunteer to participate in these clinical trials, and since then it has been It is ideal for the issuance to see the state with all its institutions standing up to help us reach the target number of participants in these examinations during the first four weeks of the start of the experiments ».
He continued: “We are a nation that is proud of the existence of extraordinary people, people who come from different parts of the world and call the UAE their second home. Together, we will remain committed to reaching a global solution to the Corona pandemic.”
An effective role for humanity
The Executive Director of Medical Affairs at Sheikh Khalifa Medical City, Chairman of the Health Council for Infectious Diseases and Infection Control, Dr. Nawal Al Kaabi, said, “The submission of 15,000 volunteers to participate in clinical trials is an achievement that shows the passion and commitment of everyone who lives and works in the country to play an effective role for the sake of all humanity. ».
The CEO of "G42 Healthcare", Ashish Kochi, stated that "the 107 nationalities who volunteered are strong evidence of the correctness of the decision we have taken to encourage (Sinopharm CNBG) to partner with us in the UAE due to the multiethnic and diverse and wide demographics. Of the country's population ».
He added that the joint scientific and clinical teams are working to ensure the smooth management of the 15,000 volunteers, during each stage of their 42-day journey, which includes regular checks and return to obtain a second dose of the potential vaccine.
"The speed of these experiments so far and the amazing ethnic diversity of the vaccinated volunteers confirm the correctness of our decision that the UAE is an ideal location to test our potential vaccine, and to reach the widest population and ethnic group," said Jing Jin Zhu, head of biological products at Sinopharm CNBG. Of volunteers ».
Promote the health of the population
The "G42 Healthcare" company has expanded the cycle of the first trials in the world for the third phase of the inactive vaccine for "Covid-19" from "Sinopharma CNBG" to include a new center in Bahrain that is currently witnessing the delivery of the vaccine to the first group of volunteers in the Kingdom.
This trial is part of a series of national initiatives to promote the health of the population, and to enhance the capabilities of medical research and development in the UAE, including the local capacity to manufacture the vaccine.
Work is progressing in full swing to open more centers in additional locations, to ensure the participation of the largest number of individuals and join the "For Humanity" campaign.